Clorox Co (CLX) is overvalued and Unilever plc ADR (UL) is overvalued.
Both trade above our estimate of their intrinsic value. UL is the closer of the two: -34%, against -87% for CLX.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $46.51; the price of $87.15 is 87% above that value, and 81% of that value comes from beyond year five.
Leak Score 44/100 on 2 of 12 signals
Discounting its cash flows at 7.3% (average of 3 methods) values the shares at $47.06; the price of $62.93 is 34% above that value, and 81% of that value comes from beyond year five.
Leak Score 59/100 on 3 of 12 signals
| Metric | CLX | UL |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Price | $87.15 | $62.93 |
| Intrinsic value | $46.51 | $47.06 |
| Margin of safety | -87% | -34% |
| Leak Score | 44/100 (2/12) | 59/100 (3/12) |
| Market cap | $10.5B | $135.6B |
| Revenue growth, 5 years | -1.8% | -0.3% |
| Operating margin | 13.2% | 20.3% |
| Net margin | 8.7% | 12.2% |
| Return on equity | 285.6% | 30.8% |
| Debt to equity | 62.02 | 1.98 |
| P/E | 18.1x | 21.0x |
| Forward P/E | 13.9x | 16.0x |
| P/B | 117.1x | 7.3x |
| Dividend yield | 5.8% | 3.5% |